CTS/$CTS
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About CTS
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEMs) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China, Singapore, the Czech Republic, Taiwan, Denmark, and other countries.
- Ticker
- $CTS
- Sector
- Digital Hardware
- Primary listing
- NYSE
- Employees
- 3,492
- Headquarters
- Lisle, United States
- Website
- www.ctscorp.com
CTS Metrics
BasicAdvanced
$1.7B
23.99
$2.54
0.99
$0.16
0.26%
Price and volume
Market cap
$1.7B
Beta
0.99
52-week high
$69.55
52-week low
$40.15
Average daily volume
247K
Dividend rate
$0.16
Financial strength
Current ratio
2.593
Quick ratio
1.974
Long term debt to equity
0.144
Total debt to equity
0.151
Dividend payout ratio (TTM)
6.24%
Interest coverage (TTM)
33.78%
Profitability
EBITDA (TTM)
134.726
Gross margin (TTM)
40.62%
Net profit margin (TTM)
12.94%
Operating margin (TTM)
17.47%
Effective tax rate (TTM)
33.51%
Revenue per employee (TTM)
$160,000
Management effectiveness
Return on assets (TTM)
7.73%
Return on equity (TTM)
13.02%
Valuation
Price to earnings (TTM)
23.988
Price to revenue (TTM)
3.066
Price to book
2.96
Price to tangible book (TTM)
7.25
Price to free cash flow (TTM)
16.159
Free cash flow yield (TTM)
6.19%
Free cash flow per share (TTM)
3.776
Dividend yield (TTM)
0.26%
Forward dividend yield
0.26%
Growth
Revenue change (TTM)
7.61%
Earnings per share change (TTM)
34.02%
3-year revenue growth (CAGR)
0.17%
10-year revenue growth (CAGR)
3.93%
3-year earnings per share growth (CAGR)
10.21%
10-year earnings per share growth (CAGR)
20.94%
What the Analysts think about CTS
Analyst ratings (Buy, Hold, Sell) for CTS stock.
Analyst projections of the future price of CTS stock.
Bulls say / Bears say
CTS raised its 2026 sales outlook to $580–590 million and adjusted EPS outlook to $2.78–2.88 after another year-on-year increase in quarterly sales and earnings. That signals stronger near-term operating momentum than management had previously expected. (GlobeNewswire)
Industrial sales grew 7% and bookings exceeded shipments, while aerospace and defence bookings were also strong, with a 1.91 book-to-bill ratio. Those order trends could support future growth across markets beyond transport. (Investing.com)
The completed $50 million Millar acquisition adds advanced pressure-sensing technology for medical, life-sciences and industrial uses. It gives CTS another route to broaden its customer base beyond transport. (CTS Corporation)
Management expects global light-vehicle production to be flat to modestly lower, citing tariff, geopolitical and consumer-demand uncertainty. That could constrain CTS’s transport business even as other markets grow. (Investing.com)
The 42.2% adjusted gross margin was a record, and management expects some normalisation from that level. If margins ease, recent profit growth may be harder to sustain. (Investing.com)
Medical bookings lagged shipments, with a book-to-bill ratio of 0.66 as new business wins were affected by order timing. If bookings do not recover, this could weaken near-term revenue visibility in a key growth market. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 27 Oct 2026.
CTS Financial Performance
Revenues and expenses
CTS Earnings Performance
Company profitability
Upcoming events
CTS News
AllArticlesVideos
Funds containing CTS
Fund name | Fund size | $CTS weighting |
|---|---|---|
iShares S&P SmallCap 600$IDP6 | $2.5B | 0.10% |
iShares S&P Small Cap 600£ISP6 | $2.5B | 0.10% |
SPDR Russell 2000 US Small Cap€R2US | $4.7B | 0.06% |
SPDR Russell 2000 US Small Cap£R2SC | $4.7B | 0.06% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | $2.7B | 0.02% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
